147 related articles for article (PubMed ID: 32768649)
1. Discovery of a d-pro-lys peptidomimetic inhibitor of MMP9: Addressing the gelatinase selectivity beyond S1' subsite.
Lenci E; Contini A; Trabocchi A
Bioorg Med Chem Lett; 2020 Oct; 30(20):127467. PubMed ID: 32768649
[TBL] [Abstract][Full Text] [Related]
2. Identification of highly potent and selective MMP2 inhibitors addressing the S1' subsite with d-proline-based compounds.
Lenci E; Innocenti R; Di Francescantonio T; Menchi G; Bianchini F; Contini A; Trabocchi A
Bioorg Med Chem; 2019 May; 27(9):1891-1902. PubMed ID: 30926311
[TBL] [Abstract][Full Text] [Related]
3. Multitargeting application of proline-derived peptidomimetics addressing cancer-related human matrix metalloproteinase 9 and carbonic anhydrase II.
Lenci E; Angeli A; Calugi L; Innocenti R; Carta F; Supuran CT; Trabocchi A
Eur J Med Chem; 2021 Mar; 214():113260. PubMed ID: 33581552
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.
Yan Y; Chen X; Yang X; Zhang J; Xu W; Zhang Y
Bioorg Med Chem; 2015 Oct; 23(20):6632-40. PubMed ID: 26386821
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of potent hydroxamate inhibitors with increased selectivity within the gelatinase family.
Zapico JM; Puckowska A; Filipiak K; Coderch C; de Pascual-Teresa B; Ramos A
Org Biomol Chem; 2015 Jan; 13(1):142-56. PubMed ID: 25348733
[TBL] [Abstract][Full Text] [Related]
6. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
[TBL] [Abstract][Full Text] [Related]
8. Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.
Shi L; Wang Q; Wang H; Zhou H; Li Y; Li X
Bioorg Med Chem; 2013 Dec; 21(24):7752-62. PubMed ID: 24247003
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Tetrahydro-β-carboline Derivatives as Selective Sub-Nanomolar Gelatinase Inhibitors.
Mangiatordi GF; Guzzo T; Rossano EC; Trisciuzzi D; Alberga D; Fasciglione G; Coletta M; Topai A; Nicolotti O
ChemMedChem; 2018 Jul; 13(13):1343-1352. PubMed ID: 29893479
[TBL] [Abstract][Full Text] [Related]
10. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
[TBL] [Abstract][Full Text] [Related]
11. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
12. Insight into the structural requirement of aryl sulphonamide based gelatinases (MMP-2 and MMP-9) inhibitors - Part I: 2D-QSAR, 3D-QSAR topomer CoMFA and Naïve Bayes studies - First report of 3D-QSAR Topomer CoMFA analysis for MMP-9 inhibitors and jointly inhibitors of gelatinases together.
Das S; Amin SA; Jha T
SAR QSAR Environ Res; 2021 Aug; 32(8):655-687. PubMed ID: 34355614
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors.
Bertran A; Khomiak D; Konopka A; Rejmak E; Bulska E; Seco J; Kaczmarek L; Tarragó T; Prades R
Bioorg Chem; 2020 Jan; 94():103365. PubMed ID: 31676116
[TBL] [Abstract][Full Text] [Related]
14. D-proline-based peptidomimetic inhibitors of anthrax lethal factor.
Calugi C; Trabocchi A; Lalli C; Guarna A
Eur J Med Chem; 2012 Oct; 56():96-107. PubMed ID: 22960696
[TBL] [Abstract][Full Text] [Related]
15. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
[TBL] [Abstract][Full Text] [Related]
16. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide.
Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C
Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861
[TBL] [Abstract][Full Text] [Related]
17. Gelatinase inhibitors: a patent review (2011-2017).
Li X
Expert Opin Ther Pat; 2018 Jan; 28(1):31-46. PubMed ID: 29130358
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity.
Rocchi D; Blázquez-Barbadillo C; Agamennone M; Laghezza A; Tortorella P; Vicente-Zurdo D; Rosales-Conrado N; Moyano P; Pino JD; González JF; Menéndez JC
Eur J Med Chem; 2021 Jan; 210():113061. PubMed ID: 33310289
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.
Yang L; Wang P; Wu JF; Yang LM; Wang RR; Pang W; Li YG; Shen YM; Zheng YT; Li X
Bioorg Med Chem; 2016 May; 24(9):2125-36. PubMed ID: 27039251
[TBL] [Abstract][Full Text] [Related]
20. Gelatinase expression and proteolytic activity in giant-cell arteritis.
Segarra M; García-Martínez A; Sánchez M; Hernández-Rodríguez J; Lozano E; Grau JM; Cid MC
Ann Rheum Dis; 2007 Nov; 66(11):1429-35. PubMed ID: 17502363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
